Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials.

Andes, David; Kovanda, Laura; Desai, A; Kitt, Therese; Zhao, M; Walsh, Thomas J

Andes, David; Kovanda, Laura; Desai, A; Kitt, Therese; Zhao, M; Walsh, Thomas J.

Afiliação

Andes D; University of Wisconsin, Madison, Wisconsin, USA dra@medicine.wisc.edu.
Kovanda L; Astellas Pharma Global Development, Inc., Northbrook, Illinois, USA.
Desai A; Astellas Pharma Global Development, Inc., Northbrook, Illinois, USA.
Kitt T; Astellas Pharma Global Development, Inc., Northbrook, Illinois, USA.
Zhao M; University of Wisconsin, Madison, Wisconsin, USA.
Walsh TJ; Weill Cornell Medicine of Cornell University, New York Presbyterian Hospital, and Hospital for Special Surgery Henry Schueler Foundation Scholar, New York, New York, USA.

Antimicrob Agents Chemother ; 62(7)2018 07.

Article em En | MEDLINE | ID: mdl-29735569

Assuntos

Antifúngicos/farmacologia; Nitrilas/farmacologia; Piridinas/farmacologia; Triazóis/farmacologia; Ensaios Clínicos como Assunto; Humanos; Itraconazol/farmacologia; Testes de Sensibilidade Microbiana; Voriconazol/farmacologia

Palavras-chave

isavuconazole; therapeutic drug monitoring

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Triazóis / Antifúngicos / Nitrilas Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google